Attached files

file filename
8-K - 8-K - MAGELLAN HEALTH INCa10-4741_18k.htm

Exhibit 99.1

 

 

 

 

NEWS RELEASE

 

55 Nod Road

Avon, CT 06001

www.MagellanHealth.com

 

For Immediate Release

 

Investor Contact:

Renie Shapiro

 

877-645-6464

 

 

Media Contact:

Mike Fleming

 

410-953-2408

 

MAGELLAN HEALTH SERVICES REPORTS

FOURTH QUARTER AND FULL YEAR 2009 FINANCIAL RESULTS

 

AVON, Conn. — February 26, 2010 — Magellan Health Services, Inc. (Nasdaq: MGLN) today reported net revenue of $2.64 billion, net income of $106.7 million, or $3.01 per diluted common share, and segment profit of $227.2 million for the year ended December 31, 2009.

 

The Company’s segment profit, representing income from continuing operations before stock compensation expense, depreciation and amortization, interest expense, interest income, gain on sale of assets, special charges or benefits, and income taxes, increased $7.6 million over the segment profit of $219.6 million in the prior year.  For the year ended December 31, 2008, net revenue was $2.63 billion and net income was $86.2 million, or $2.16 per diluted common share.

 

For the fourth quarter of 2009, the Company reported net revenue of $718.9 million, compared with $661.8 million in the prior year fourth quarter. Net income in the quarter was $43.7 million, or $1.25 per diluted common share, compared with $23.6 million, or $0.61 per diluted common share, in the fourth quarter of 2008. Segment profit for the fourth quarter was $76.9 million, compared with $55.0 million in the prior year quarter.

 

The Company ended the quarter with unrestricted cash and investments of $263.8 million, after the impact of stock repurchases for the year of $89.7 million and the purchase of First Health Services for $115.4 million.  Cash flow from operations for 2009 was $218.6 million compared with $268.3 million for the prior year.

 

See the attached tables detailing the Company’s operating results, including results by segment.

 

René Lerer, M.D., chairman and CEO, said, “Magellan achieved significant success in 2009, driven by strong financial and operational performance across all segments, noteworthy new customer sales, and continued execution on our capital deployment and diversification strategy.  I am very pleased with these results and the solid foundation we have established for the future.”

 

Company highlights in 2009 included further diversification through the acquisition of First Health Services, which strengthened the Company’s Medicaid capabilities, and the launch of innovative specialty health care products, including oncology management and cardiac management.  Magellan also entered into several new customer contracts, most notably the agreement with WellCare Health Plans to manage behavioral health services for all WellCare markets in the continental United States.  Additionally, the Company secured multiple contract extensions in its public behavioral health sector.

 

Magellan’s 2009 results also illustrated the success of its diversification strategy, with approximately 30 percent of segment profit generated from the radiology, specialty pharmacy, and Medicaid administration business lines.

 

- more -



 

“Our strategic focus on customer retention, business growth, and clinical care management has continued to yield results across all of our lines of business,” said Karen S. Rohan, president.  “Additionally, we continue to build upon our strong foundation of clinical excellence and invest in product innovation to ensure quality outcomes for our customers and their members.”

 

Jonathan N. Rubin, chief financial officer, said, “Our financial results for 2009 reflect the strong performance of all of our businesses.  We ended the year with approximately $264 million of unrestricted cash and investments and no debt.  Our financial strength and consistent cash flow affords us the flexibility to deploy capital to fund growth initiatives, pursue acquisition opportunities, and return capital to our shareholders.”

 

Outlook

Management confirmed its guidance for 2010, stating that the Company expects to generate net revenue in the range of $3.0 billion to $3.2 billion, net income in the range of $95.5 million to $115.0 million, and segment profit in the range of $235 million to $255 million.  These results are expected to yield earnings per share in the range of $2.73 to $3.29 on a diluted basis.

 

“As our customers grapple with rising economic pressures, increasing diagnostic and treatment complexities, and the challenges associated with the management of specialty health care services, many of them are more receptive to innovative, outsourced solutions,” Lerer said.  “Over the past several months, we have met with a number of health plans and state governments who are looking to Magellan for support in addressing their specialty health care management needs.  With our comprehensive, multi-specialty solutions, we are uniquely positioned to respond to this market opportunity.”

 

Earnings Results Conference Call

Management will host a conference call at 9:00 a.m. Eastern time on Friday, February 26. To participate in the conference call, interested parties should call 1-888-566-8408 and reference the passcode Fourth Quarter 2009 Earnings Call approximately 15 minutes before the start of the call.

 

The conference call also will be available via a live Webcast at Magellan’s investor relations page at www.MagellanHealth.com.

 

A taped replay of the conference call will be available for one week following the call. Interested parties should call 888-562-2771 or 402-998-1438 (from outside the U.S.).

 

About Magellan:  Headquartered in Avon, Conn., Magellan Health Services, Inc. (Nasdaq: MGLN) is a leading specialty health care management organization. Its customers include health plans, corporations and government agencies.

 

Cautionary Statement:  This release contains forward-looking statements within the meaning of the Securities Exchange Act of 1934 and the Securities Act of 1933, as amended, that involve a number of risks and uncertainties. All statements, other than statements of historical information provided herein, may be deemed to be forward-looking statements including, without limitation, statements regarding estimates of 2010 net revenue, net income, segment profit, and earnings per share. These statements are based on management’s analysis, judgment, belief and expectation only as of the date hereof, and are subject to uncertainty and changes in circumstances. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “may,” “should,” “could,” “estimate,” “intend” and other similar expressions are intended to identify forward-looking statements. Actual results could differ materially due to, among other things, the possible election of certain of the Company’s customers to manage the health care services of their members directly; changes in rates paid to and/or by the Company by customers and/or providers; higher utilization of health care services by the Company’s risk members; delays, higher costs or inability to implement new business or other Company initiatives; the impact of changes in the contracting model for Medicaid contracts; termination or non-renewal of customer contracts; the impact of new or amended laws or regulations;

 

2



 

governmental inquiries; litigation; competition; operational issues; health care reform; and general business conditions. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included within the Company’s Annual Report on Form 10-K for the year ended December 31, 2009, to be filed with the Securities and Exchange Commission today and posted on the Company’s Web site. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date of this release. Segment profit information referred to herein may be considered a non-GAAP financial measure.  Further information regarding this measure, including the reasons management considers this information useful to investors, will be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.

 

# # #

 

3



 

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)

 

 

 

Three Months Ended December 31,

 

Year Ended December 31,

 

 

 

2008

 

2009 (1)

 

2008

 

2009 (1)

 

 

 

(unaudited)

 

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

661,784

 

$

718,909

 

$

2,625,394

 

$

2,641,814

 

 

 

 

 

 

 

 

 

 

 

Cost and expenses:

 

 

 

 

 

 

 

 

 

Cost of care

 

461,794

 

455,540

 

1,830,542

 

1,765,313

 

Cost of goods sold

 

46,838

 

51,839

 

181,356

 

203,336

 

Direct service costs and other operating expenses (2)

 

104,517

 

137,678

 

426,627

 

465,710

 

Depreciation and amortization

 

15,827

 

13,555

 

60,810

 

47,268

 

Interest expense

 

22

 

690

 

2,846

 

2,424

 

Interest income

 

(3,694

)

(985

)

(17,030

)

(6,245

)

 

 

625,304

 

658,317

 

2,485,151

 

2,477,806

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations before income taxes

 

36,480

 

60,592

 

140,243

 

164,008

 

Provision for income taxes

 

12,896

 

16,867

 

54,038

 

57,337

 

Net income

 

23,584

 

43,725

 

86,205

 

106,671

 

Other comprehensive income (loss)

 

2,013

 

110

 

147

 

(58

)

Comprehensive income

 

$

25,597

 

$

43,835

 

$

86,352

 

$

106,613

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding — basic

 

38,464

 

34,717

 

39,607

 

35,248

 

Weighted average number of common shares outstanding — diluted

 

38,631

 

34,972

 

39,999

 

35,416

 

 

 

 

 

 

 

 

 

 

 

Net income per common share — basic

 

$

0.61

 

$

1.26

 

$

2.18

 

$

3.03

 

Net income per common share — diluted

 

$

0.61

 

$

1.25

 

$

2.16

 

$

3.01

 

 


(1)          For a more detailed discussion of Magellan’s results for the period ended December 31, 2009, refer to the Company’s Annual Report on Form 10-K which will be filed with the SEC on February 26, 2010, and the live broadcast or taped replay of the Company’s earnings conference call on February 26, 2010, which will be available at www.MagellanHealth.com.

 

(2)          Includes stock compensation expense of $6,414 and $3,058 for the three months ended December 31, 2008 and 2009, respectively, and $32,763 and $19,782 for the years ended December 31, 2008 and 2009, respectively.

 



 

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

Year Ended December 31,

 

 

 

2008

 

2009

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

86,205

 

$

106,671

 

 

 

 

 

 

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

60,810

 

47,268

 

Non-cash interest expense

 

1,423

 

899

 

Non-cash stock compensation expense

 

32,763

 

19,782

 

Non-cash income tax expense

 

42,241

 

30,033

 

Cash flows from changes in assets and liabilities, net of effects from acquisitions of businesses:

 

 

 

 

 

Restricted cash

 

60,368

 

32,736

 

Accounts receivable, net

 

(15,720

)

(3,328

)

Other assets

 

(9,290

)

(8,936

)

Accounts payable and accrued liabilities

 

11,519

 

(2,908

)

Medical claims payable and other medical liabilities

 

(426

)

(7,495

)

Other

 

(1,589

)

3,851

 

Net cash provided by operating activities

 

268,304

 

218,573

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Capital expenditures

 

(36,314

)

(33,220

)

Acquisitions and investments in businesses, net of cash acquired

 

(25,425

)

(115,438

)

Purchase of investments

 

(404,420

)

(299,357

)

Maturity of investments

 

228,392

 

298,556

 

Net cash used in investing activities

 

(237,767

)

(149,459

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Payments on long-term debt and capital lease obligations

 

(13,981

)

(3

)

Payments to acquire treasury stock

 

(136,153

)

(89,667

)

Proceeds from exercise of stock options and warrants

 

12,896

 

2,580

 

Tax benefit from exercise of stock options and vesting of stock awards

 

7,549

 

2,917

 

Other

 

(1,395

)

(259

)

Net cash used in financing activities

 

(131,084

)

(84,432

)

Net decrease in cash and cash equivalents

 

(100,547

)

(15,318

)

Cash and cash equivalents at beginning of period

 

312,372

 

211,825

 

Cash and cash equivalents at end of period

 

$

211,825

 

$

196,507

 

 



 

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except membership amounts in millions)

 

 

 

Three Months Ended December 31,

 

Year Ended December 31,

 

 

 

2008

 

2009

 

2008

 

2009

 

 

 

(unaudited)

 

(unaudited)

 

 

 

 

 

Net revenue

 

 

 

 

 

 

 

 

 

- Commercial

 

$

162,844

 

$

169,136

 

$

649,636

 

$

650,139

 

- Public Sector

 

367,115

 

361,052

 

1,451,923

 

1,362,420

 

- Radiology Benefits Management

 

71,446

 

82,848

 

295,336

 

305,251

 

- Specialty Pharmaceutical Management

 

60,379

 

67,426

 

228,499

 

259,745

 

- Medicaid Administration

 

 

38,447

 

 

64,259

 

Total net revenue

 

661,784

 

718,909

 

2,625,394

 

2,641,814

 

 

 

 

 

 

 

 

 

 

 

Cost of care

 

 

 

 

 

 

 

 

 

- Commercial

 

92,192

 

86,602

 

344,761

 

351,270

 

- Public Sector

 

314,942

 

312,302

 

1,278,316

 

1,208,451

 

- Radiology Benefits Management

 

54,660

 

56,636

 

207,465

 

205,592

 

Total cost of care

 

461,794

 

455,540

 

1,830,542

 

1,765,313

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold - Specialty Pharmaceutical Management

 

46,838

 

51,839

 

181,356

 

203,336

 

 

 

 

 

 

 

 

 

 

 

Direct service costs and other operating expenses

 

 

 

 

 

 

 

 

 

- Commercial

 

41,306

 

37,904

 

154,894

 

152,280

 

- Public Sector

 

17,779

 

17,189

 

68,914

 

67,835

 

- Radiology Benefits Management

 

13,074

 

13,345

 

54,482

 

51,732

 

- Specialty Pharmaceutical Management

 

6,859

 

6,121

 

25,623

 

24,901

 

- Medicaid Administration

 

 

32,736

 

 

54,874

 

- Corporate & Other

 

25,499

 

30,383

 

122,714

 

114,088

 

Total direct services costs and other operating expenses

 

104,517

 

137,678

 

426,627

 

465,710

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense (1)

 

 

 

 

 

 

 

 

 

- Commercial

 

(271

)

(222

)

(1,368

)

(953

)

- Public Sector

 

(241

)

(134

)

(839

)

(690

)

- Radiology Benefits Management

 

(376

)

(314

)

(1,472

)

(1,260

)

- Specialty Pharmaceutical Management

 

(2,522

)

(736

)

(8,967

)

(5,383

)

- Medicaid Administration

 

 

331

 

 

(27

)

- Corporate & Other

 

(3,004

)

(1,983

)

(20,117

)

(11,469

)

Total stock compensation expense

 

(6,414

)

(3,058

)

(32,763

)

(19,782

)

 

 

 

 

 

 

 

 

 

 

Segment profit (loss)

 

 

 

 

 

 

 

 

 

- Commercial

 

29,617

 

44,852

 

151,349

 

147,542

 

- Public Sector

 

34,635

 

31,695

 

105,532

 

86,824

 

- Radiology Benefits Management

 

4,088

 

13,181

 

34,861

 

49,187

 

- Specialty Pharmaceutical Management

 

9,204

 

10,202

 

30,487

 

36,891

 

- Medicaid Administration

 

 

5,380

 

 

9,412

 

- Corporate & Other

 

(22,495

)

(28,400

)

(102,597

)

(102,619

)

Total segment profit

 

$

55,049

 

$

76,910

 

$

219,632

 

$

227,237

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of segment profit to income from continuing operations before income taxes:

 

 

 

 

 

 

 

 

 

Segment profit

 

$

55,049

 

$

76,910

 

$

219,632

 

$

227,237

 

Stock compensation expense

 

(6,414

)

(3,058

)

(32,763

)

(19,782

)

Depreciation and amortization

 

(15,827

)

(13,555

)

(60,810

)

(47,268

)

Interest expense

 

(22

)

(690

)

(2,846

)

(2,424

)

Interest income

 

3,694

 

985

 

17,030

 

6,245

 

Income from continuing operations before income taxes

 

$

36,480

 

$

60,592

 

$

140,243

 

$

164,008

 

 

 

 

 

 

 

 

 

 

 

Membership

 

 

 

 

 

 

 

 

 

- Commercial

 

 

 

 

 

 

 

38.0

 

- Public Sector

 

 

 

 

 

 

 

1.9

 

- Radiology Benefits Management

 

 

 

 

 

 

 

17.5

 

Total membership

 

 

 

 

 

 

 

57.4

 

 


(1)          Stock compensation expense is included in direct service costs and other operating expenses; however, this amount is excluded from the computation of segment profit since it is managed on a consolidated basis.